Stifel raised the firm’s price target on Alignment Healthcare (ALHC) to $23 from $18 and keeps a Buy rating on the shares. CMS released its Final Rate Notice for 2026 after the close and the rates came in significantly above expectations, rising 283 basis points compared to the Advance Rate Notice released in January after incorporating Q4 data, the analyst tells investors.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ALHC:
- Alignment Healthcare, Sutter Health renew long-term, strategic collaboration
- Alignment Healthcare management to meet with Stephens
- Alignment Healthcare price target raised to $18.50 from $15.50 at BofA
- Alignment Healthcare price target raised to $21 from $14 at Piper Sandler
- Alignment Healthcare Reports Strong Growth in Earnings Call